Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Dhiti Omics logo — Precision Molecular Diagnostics & Genetic Testing

Dhiti Omics

Precision Molecular Diagnostics & Genetic Testing

Founded 2014 India Bengaluru, India 15 employees Seed Biotechnology, Health Care

General Information

Company Name Dhiti Omics
Founded Year 2014
Location India Bengaluru, India
Employees 15
Industries Biotechnology, Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Dhiti Omics. To contact Dhiti Omics, visit dhitiomics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Dhiti Omics compare?

A PDF of Dhiti Omics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Dhiti Omics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Dhiti Omics

Dhiti Omics is a precision molecular diagnostics service provider specializing in Rare Disease, Inherited Disorders, Oncology, Pharmacogenomics, and Infectious Disease diagnosis. Utilizing state-of-the-art genomics technologies such as Next Generation Sequencing, Microarrays, Sanger Sequencing, PCR and qRT-PCR, the company aims to offer deeper insights into the diagnosis of rare and difficult diseases. Founded in 2014 and headquartered in India, Dhiti Omics collaborates with subject matter experts to provide genomic-based clinical diagnostics and research services. The company's focus lies on early disease detection, risk stratification, prognostication, and the prediction of therapy response. Dhiti Omics secured its Seed Round investment on 30 March 2016. With its specialization in the biotechnology and healthcare industries, this startup is poised to make significant strides in precision medicine and genetic testing.

Business keywords: Precision Molecular Diagnostics, Genetic Testing, Rare Diseases, Inherited Disorders, Oncology, Pharmacogenomics, Infectious Diseases, Next Generation Sequencing, Sanger Sequencing, Microarray, PCR, RT-PCR, Clinical Genomics, Rare Disease Diagnosis, Genomic-based Clinical Diagnostics

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed -
30 Mar 2016

Dhiti Omics Alternatives & Competitors

View All Alternatives
Dhiti Omics vs
MEDGENOME
MEDGENOME India

Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions

Series D
1011 employees
Biotechnology, Health Care
Compare Dhiti Omics vs MEDGENOME
Dhiti Omics vs
G2M | Next Generation IVD solutions for Genomics
G2M | Next Generation IVD solutions for Genomics India

Revolutionizing Molecular Diagnostics with world-class Innovative IVD Solutions.

103 employees
Biotechnology, Health Care
Dhiti Omics vs
GenePath Diagnostics
GenePath Diagnostics United States

Better Healthcare Through Next Generation Diagnostics

Venture round
56 employees
Biotechnology, Health Care
Compare Dhiti Omics vs GenePath Diagnostics
Also compare with: Dhiti Omics vs CENTOGENE CENTOGENE View all alternatives

FAQ About Dhiti Omics

Precision Molecular Diagnostics & Genetic Testing
Dhiti Omics was founded in 2014.
Dhiti Omics is headquartered in Bengaluru, India.
Dhiti Omics operates in Biotechnology and Health Care. Its work centres on Precision Molecular Diagnostics, Genetic Testing, Rare Diseases and Inherited Disorders.
Dhiti Omics has approximately 15 employees.
Dhiti Omics has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Dhiti Omics include MEDGENOME, G2M | Next Generation IVD solutions for Genomics, GenePath Diagnostics, Mendelics, CENTOGENE. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Dhiti Omics and MEDGENOME are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Dhiti Omics, https://bouncewatch.com/company/dhiti-omics, updated 29 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes